Intas Pharmaceuticals Limited Clopidogrel Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Clopidogrel Export Records India — #14 Exporter, 301 Shipments, $5.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Clopidogrel

India Pharmaceutical Trade Intelligence

$251.3M416 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES32.3%India → UNITED KINGDOM9.1%

ImportsFRANCE → India$1.7B ISRAEL → India$2.1M

#1 Buyer: NORTHSTAR DISTRIBUTION

Intas Pharmaceuticals Limited — Clopidogrel Exporter #14 | $5.3M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Clopidogrel Exporter Profile

Indian Pharmaceutical Exporter · #14 for Clopidogrel · $5.3M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #14 Indian exporter of Clopidogrel with $5.3M in export value and 301 verified shipments. Intas Pharmaceuticals Limited holds a 2.1% market share in Clopidogrel exports across 19 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Clopidogrel Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Clopidogrel export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Clopidogrel?

Country	Value	Shipments	Share
AUSTRALIA	$2.2M	62	51.2%
NETHERLANDS	$785.8K	66	18.5%
BRAZIL	$526.7K	20	12.4%
UNITED KINGDOM	$245.7K	21	5.8%
SOUTH AFRICA

Who Are the Top Buyers of Clopidogrel from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
SANDOZ PTY LTD	AUSTRALIA	$908.2K	27
TO THE ORDER	HUNGARY	$642.4K	52
BROCACEF NL : HUB	NETHERLANDS	$466.1K	39
SANDOZ PTY LIMITED	AUSTRALIA	$463.6K	13
SANDOZ PTY LTD.	AUSTRALIA	$327.6K	8
ACCORD FARMACUTICA LTDA.	BRAZIL	$302.2K	14
ACCORD FARMACUTICA LIMITEDA	BRAZIL	$224.5K	5
ACCORD UK	UNITED KINGDOM	$158.1K	13
ALLOGA FRANCE	NETHERLANDS	$130.3K	8
ACCORD HEALTHCARE C/O UPD LEA GLEN	SOUTH AFRICA	$110.4K	5

Intas Pharmaceuticals Limited supplies Clopidogrel to 33 buyers globally. The largest buyer is SANDOZ PTY LTD (AUSTRALIA), followed by TO THE ORDER (HUNGARY) and BROCACEF NL : HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Clopidogrel Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI CLOPIDOGREL TABLETS	$345.2K	9
PHRM DRUG&MED:CLOPIDOGREL SANDOZ 75MG 2X	$328.8K	7
PHARM DRUG&MED:CLOPIDOGREL SANDOZ 75MG 2X14T(SAN-AUS)EACH FILM COA TAB CONT:CLOPID BISULFATE USP EQ TO CLOPIDO(ASPERINV)TBS	$326.1K	12
PHARMA DRUGS & MEDI CLOPIDOGREL 75MG 2X1	$205.1K	11
PHARMA DRUGS & MEDI CLOPIDOGREL ACCORD 75MG 10X10T(ACOR-SWED AS PER INVOICE	$189.3K	20
PHARM DRUG&MED:CLOPIDOGREL SANDOZ 75MG 2X14T(SAN-AUS) EACH FILM COATED TABLET CONT:CLOPIDOGREL BISULFATE USP(ASPERINV)	$178.0K	4
PHARM DRUG&MED:CLOPIDOGREL SANDOZ 75MG 2X14T(SAN-AUS)EACH FILM COATED TABLET CONT CLOPIDOGREL BISULFATE USP EQ(ASPERINV)	$142.0K	4
PHARM DRUG&MED:CLOPIDOGREL SANDOZ 75MG 2X14T(SAN-AUS)EACH FILM COAT TABLET CONT:CLOPIDOGREL BISULFATE USP EQ TO(ASPERINV	$136.3K	3
PHARMA DRUGS & MEDI CLOPIDOGREL ACCORD 7	$123.5K	5
PHARM DRUG&MED: CLOPIDOGREL SANDOZ 75MG	$100.0K	2

Intas Pharmaceuticals Limited exports 131 distinct Clopidogrel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI CLOPIDOGREL TABLETS with 9 shipments worth $345.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Clopidogrel Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$7.5M	150	13	$50.0K
8	AJANTA PHARMA LIMITED	$7.0M	140	18	$50.0K
14	INTAS PHARMACEUTICALS LIMITED ★	$5.3M	301	19	$17.6K
9	SANDOZ PRIVATE LIMITED	$5.3M	105	7	$50.0K
15	MICRO LABS LIMITED	$5.2M	217	20	$24.0K

Intas Pharmaceuticals Limited ranks #14 among 416 Indian Clopidogrel exporters. Average shipment value of $17.6K compared to the market average of $320.2K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and AJANTA PHARMA LIMITED.

Which Indian Ports Ship Clopidogrel Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	576	9.5%
HYDERABAD ICD (INSNF6)	490	8.1%
HYDERABAD ICD	408	6.8%
SAHAR AIR CARGO ACC (INBOM4)	366	6.1%
SAHAR AIR	350	5.8%
JNPT/ NHAVA SHEVA SEA	295	4.9%
DELHI AIR CARGO ACC (INDEL4)	267	4.4%
DELHI AIR	256	4.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Clopidogrel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clopidogrel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 303 individual customs records matching Intas Pharmaceuticals Limited exporting Clopidogrel, covering 131 formulations to 20 countries via 33 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 1,234+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clopidogrel

Clopidogrel

Intas Pharmaceuticals Limited — Clopidogrel Exporter Profile

Intas Pharmaceuticals Limited — Clopidogrel Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Clopidogrel?

Who Are the Top Buyers of Clopidogrel from Intas Pharmaceuticals Limited?

What Is India's Total Clopidogrel Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Clopidogrel Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Clopidogrel Exporters?

What Clopidogrel Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Clopidogrel to Key Markets

Australia — TGA

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Clopidogrel Exporters?

Which Indian Ports Ship Clopidogrel Exports?

What Other Cardiovascular Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Clopidogrel Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clopidogrel Export Data from Intas Pharmaceuticals Limited

Clopidogrel Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source